Elutia Sheds Legacy Business to Chase $1.5 Billion Market Opportunity

기사 요약

Elutia (NASDAQ:ELUT) sells SimpliDerm to Cellution Biologics for up to $11M to boost its balance sheet ahead of the NXT-41x launch.